• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Laparoscopic Total Mesorectal Excision for Middle and Low Rectal Adenocarcinoma with or Without Sphincter Preservation: A Prospective Study

Laparoscopic Total Mesorectal Excision for Middle and Low Rectal Adenocarcinoma with or Without Sphincter Preservation: A Prospective Study

Background: Reports on laparoscopic total mesorectum excision (TME) for cancer are often retrospective and contain heterogeneous patients who had several types of resection (i.e., anterior resection, low anterior resection, all or partially laparoscopic). The goal of this study was to assess the feasibility, safety, and effectiveness with respect to perioperative and oncological outcomes in two prospective series of all laparoscopic total mesorectal excision for rectum adenocarcinoma, one with, the other without anal sphincter preservation.

Patients and Methods:
Between November 2000 and July 2008, 104 unselected patients had laparoscopic TME for rectal adenocarcinoma. Patients with locally advanced rectal carcinoma (uN+/uT4) occasionally underwent preoperative radiation or chemoradiation. Postoperatively, adjuvant treatment was administered to patients with UICC stage II/III disease. All patients were followed up prospectively. Survival probability analysis was performed using the Kaplan-Meier method.

Results : There were 51 women and 52 men of a mean age of 58 years (range, 21-86). Conversion to laparotomy was necessary in 6 cases (5.7 %). Average operative time was 210 min (range, 120-550). One patient required blood transfusion (0.9 %). Intra-operative complications occurred in 5 patients (4.8 %) (2 left ureteral injuries, 2 splenic injuries, 1 vaginal tear, and 1 deferent duct section). There was one postoperative death (0.9 %). The most common postoperative complication was deep abscess in 9 patients (8.6 %) associated with anastomotic leakage in 7 patients (6.7 %) and with wound infection in 6 patients (5.7 %). Other complications included pneumonia (5 patients), urinary infection (5 patients), intestinal obstruction (2 patients), and miscellaneous (4 patients).
There were 71 sphincter-preserving procedures and 23 abdominoperineal resections. All but one resection margins were uninvolved. Among the former, 22 were performed for very low tumors, located within 4 cm of the dentate line. The average length of distal margins was 5.5 cm (range, 0-11). The mean number of harvested lymph nodes removed was 15 (range, 0-45) and mean length of the resected specimen was 28 cm (range, 20-101). Although resection was intended to be curative in all 84 patients, the distal margin (dentate line) was considered to be positive in one patient (0.9 %).
All patients were followed-up for an average of 62 months (range, 12-112). The most common late complications were incisional hernia in 8 patients (7.7 %) and intestinal obstruction in 4 patients (3.8 %). No port-site metastases occurred. Recurrence developed in 49 patients (47.1 %) including distant or peritoneal metastases (32 patients) and loco-regional recurrence (11 patients). Four patients had both local and distant metastases. Overall local recurrence rate was 10.6 %.

Conclusions: Laparoscopic total mesorectal excision for rectal cancer is a feasible and safe procedure. Oncological appropriateness is respected. However, large scale randomized studies are still needed in order to more accurately evaluate its efficacy and efficiency.


Session: Poster

Program Number: P131

View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search